Table 1. Screening of active compounds using ADMET criteria.

Sl. No	Compound Names	PubChem CID	Oral bioavailability (OB≥30%)	Druglikeness (DL≥ 0.18)	Lipinski’s rule of five (LR)	Clearness (CL 5 ≥ 15 ml/min/kg)	Drug half-life (HL<3h)	Molecular Weight (MW 100–600)	Hydrogen bond acceptor (0~12)	Hydrogen bond donor (0~7)	TPSA (0–140)
1	Dihydroquercetin	439533	Moderate	2.30	Accepted	9.517	0.850	304.060	7	5	127.450
2	Tetrahydrosappanone A trimethyl ether	6708784	Pass	1.35	Accepted	11.315	0.478	330.150	5	1	57.150
3	7-Hydroxyetodolac	14112821	Pass	1.68	Accepted	6.427	0.830	303.150	5	3	82.550
4	Deoxysappanone B 7,3’-dimethyl ether acetate	6708755	Pass	1.32	Accepted	6.435	0.318	356.130	6	0	71.060
5	Cortol	246873	Moderate	0.49	Accepted	11.072	0.202	368.260	5	5	101.150
6	Tiamulin	656958	Pass	1.31	Accepted	15.755	0.358	493.320	5	1	66.840
7	p-γ-Dihydroxyphenylbutazone	4781	Pass	6.74	Accepted	12.780	0.882	340.140	6	3	89.870
8	Didesmethylimipramine	159642	Moderate	0.45	Accepted	10.188	0.085	252.160	2	2	29.260
9	Trimipramine	5584	Pass	5.25	Accepted	10.654	0.045	294.210	2	0	6.480
10	(1-Cyclopropylethyl) methylamine	16772299	Pass	2.81	Accepted	10.507	0.495	99.100	1	1	12.030
11	Stigmasta-4,6,22-trien-3beta-ol	91744920	Moderate	1.03	Accepted	15.413	0.026	410.350	1	1	20.230
12	Caffeic acid	689043	Moderate	1.62	Accepted	10.973	0.930	180.040	4	3	77.760
13	Syringic acid	10742	Pass	1.99	Accepted	7.208	0.946	198.050	5	2	75.990